Evaluating the in vivo Th2 priming potential among common allergens

Area of Science:

• Immunology
• Allergy Research

Background:

• Allergen exposure is linked to increased allergy and asthma.
• Interleukin-4 (IL-4) production by Th2 cells is key in allergic disease pathogenesis.

Purpose of the Study:

• To develop a novel in vivo model for studying primary Th2 immune responses.
• To establish a standardized method for assessing allergenicity and screening inhibitors.

Main Methods:

• Utilized the transgenic G4 mouse expressing green fluorescent protein (GFP) as an IL-4 surrogate.
• Developed an intradermal immunization technique to create the primary Th2 (PTh2) response model.
• Evaluated various allergens (environmental and food) and immunomodulatory agents.

Main Results:

• The PTh2 assay revealed a dose-dependent hierarchy of allergenicity, with environmental allergens being most potent.
• Demonstrated the assay's sensitivity to the effects of Mycobacterial extracts and immunosuppressive drugs.
• Showcased the model's ability to track IL-4 producing cells.

Conclusions:

• The PTh2 assay is a unique and standardized tool for identifying protein properties related to allergenicity.
• This model serves as a powerful screening platform for novel compounds targeting Th2 responses in allergic diseases.